The RevitaLash class action settlement pays U.S. buyers of RevitaLash and RevitaBrow serums purchased between January 1, 2017 and December 29, 2025, with a claim deadline of April 20, 2026. The total value is $4.17 million, and eligible class members can choose either a pro-rated cash payment or a $110 product voucher. Claims are filed at EyeSerumSettlement.com.
Who Qualifies
You qualify if you bought any of the covered products in the United States during the class period. The covered products are:
- RevitaLash Advanced Eyelash Conditioner
- RevitaLash Advanced Sensitive Eyelash Conditioner
- RevitaLash Advanced Pro Eyelash Conditioner
- RevitaBrow Advanced Eyebrow Conditioner
The class period runs from January 1, 2017 through December 29, 2025. Purchases outside the United States are not covered.
What You Can Get
The $4,170,000 settlement is split into a $3,036,000 cash fund and a $1,134,000 voucher fund. Every claimant chooses between cash or a $110 voucher redeemable at RevitaLash.com. The vouchers don’t expire, they transfer to someone else if you’d rather give yours away, and they stack with other discount codes.
What you can claim depends on whether you have proof of purchase, which includes being found in Athena’s own sales records:
- With proof of purchase: a pro-rated cash payment or a $110 voucher for each product claimed. If you have proof, you can also choose to take one cash payment and one voucher together.
- Without proof of purchase: one cash payment or one $110 voucher per household, with no documentation required beyond the claim form.
Cash amounts are pro-rated against the number of valid claims and what remains in the fund after administrative costs and attorney fees. Pro-rating cannot drop a cash payment below $20.
How to File
File online at EyeSerumSettlement.com, or download the paper claim form from the same site and mail it in. The deadline is April 20, 2026. If you have receipts, order confirmations, or account records from a retailer or from RevitaLash.com, keep them attached to your claim; that unlocks the per-product option.
If You Want to Opt Out or Object
April 20, 2026 is also the deadline to exclude yourself from the settlement or file a written objection. Opting out means you give up any settlement benefit but keep the right to sue Athena Cosmetics on your own. Doing nothing means you’re in the class, bound by the release, but you won’t receive a payment or voucher unless you actually file a claim.
When Payments Go Out
The final approval hearing is set for May 21, 2026 at 10:00 a.m. before Judge Hernán D. Vera in Courtroom 5B of the U.S. Courthouse in Los Angeles. At that hearing, the court decides whether to approve the settlement and rules on the attorney fee request, which comes out of the cash fund. No cash or vouchers are distributed until the court grants final approval and any appeals are resolved. Expect a wait after the May hearing before checks and voucher codes arrive.
What the Lawsuit Claimed
The case turned on an ingredient called dechloro dihydroxy difluoro ethylcloprostenolamide, or DDDE, a prostaglandin analog used in RevitaLash Advanced and related products. Prostaglandin analogs were originally developed as prescription glaucoma drugs, and the eyelash-growth effect was a side effect of that class of medication. The lead complaint, filed by Rebecca Rush, alleged that Athena sold the serums as cosmetics while concealing a drug-class ingredient and its risks, and highlighted benign components like ginseng and green tea in its marketing instead.
The alleged undisclosed side effects included blepharitis, meibomian gland dysfunction, chronic dry eye, redness, iris color change, orbital fat loss that can create a sunken look around the eyes, interference with glaucoma treatments that lower eye pressure, and eyelash or eyebrow loss rather than growth. Claims were brought under California’s Unfair Competition Law, the Consumers Legal Remedies Act, and the False Advertising Law. The complaint also cited the European Union’s Scientific Committee on Consumer Safety, which issued a final opinion in February 2026 calling DDDE “unsafe for use in cosmetic products.”
Athena Cosmetics denies wrongdoing and did not admit liability in settling. As part of the deal, the company agreed to change its labels, packaging, and website descriptions to disclose potential health risks more accurately.